WuXi AppTec at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
WuXi AppTec brings 2 presentations to ObesityWeek 2026 in National Harbor, and exhibits at Booth 123. Its program centres on preclinical models for testing treatments for obesity and metabolic liver disease. It covers new high-fat diets that quickly produce mouse models of MASH and an siRNA that knocks down ALK7 to improve the response to tirzepatide while preserving lean mass.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
WuXi AppTec Shanghai, China | |
Contract research, development and manufacturing company whose preclinical services include mouse models of obesity and metabolic liver disease for drug testing. | Booth Exhibiting at Booth 123 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm Poster Sat Nov 14 7:30pm–8:30pm SiRNA‑Mediated ALK7 Knockdown Improves Metabolic Response to Tirzepatide and Preserves Lean Mass Metabolism and integrative physiology Poster Sat Nov 14 7:30pm–8:30pm Novel High‑Fat Diets Rapidly Produce Next‑Generation Mouse Models of Metabolic Dysfunction-Associated Steatohepatitis Metabolism and integrative physiology |
Find decision makers at WuXi AppTec
Tell us what you sell and we’ll find the people at WuXi AppTec most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction